{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T20:09:11Z","timestamp":1649189351495},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1007\/s12094-008-0251-x","type":"journal-article","created":{"date-parts":[[2008,9,27]],"date-time":"2008-09-27T13:18:26Z","timestamp":1222521506000},"page":"560-571","source":"Crossref","is-referenced-by-count":3,"title":["Adjuvant chemotherapy for early-stage non-small-cell lung cancer. Single-centre experience and literature review"],"prefix":"10.1007","volume":"10","author":[{"given":"Ana Bel\u00e9n","family":"Custodio Carretero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 \u00c1ngel","family":"Garc\u00eda S\u00e1enz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"Gonz\u00e1lez Larriba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana","family":"Bobokova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Calles Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florentino","family":"Hernando Trancho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Garc\u00eda Paredes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Rodr\u00edguez Lajusticia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"D\u00edaz-Rubio Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,9,28]]},"reference":[{"key":"251_CR1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","volume":"57","author":"A. Jemal","year":"2007","unstructured":"Jemal A, Siegel R, Ward E et al (2007) Cancer statistics, 2007. CA Cancer J Clin 57:43\u201366","journal-title":"CA Cancer J Clin"},{"key":"251_CR2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/ijc.1440","volume":"94","author":"D.M. Parkin","year":"2001","unstructured":"Parkin DM, Bray F, Ferlay J, Pisani P (2001) Estimating the world cancer burden: Globoscan 2000. Int J Cancer 94:153\u2013156","journal-title":"Int J Cancer"},{"key":"251_CR3","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ijc.2910550604","volume":"55","author":"P. Pisani","year":"1993","unstructured":"Pisani P, Parkin DM, Ferlay J (1993) Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int J Cancer 55:891\u2013903","journal-title":"Int J Cancer"},{"key":"251_CR4","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1183\/09031936.01.00275301","volume":"18","author":"E. Brambilla","year":"2001","unstructured":"Brambilla E, Travis WD, Colby TV et al (2001) The new World Health Organization classification of lung tumours. Eur Respir J 18:1059\u20131068","journal-title":"Eur Respir J"},{"key":"251_CR5","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1378\/chest.111.6.1710","volume":"111","author":"C.F. Mountain","year":"1997","unstructured":"Mountain CF (1997) Revisions in the International System for Staging Lung Cancer. Chest 111:1710\u20131717","journal-title":"Chest"},{"key":"251_CR6","unstructured":"Manser R, Wright G, Hart D et al (2005) Surgery for early stage non-small cell lung cancer. Cochrane Database Syst Rev Jan 25;1:CD 004699"},{"key":"251_CR7","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/thx.2005.051995","volume":"61","author":"G. Wright","year":"2006","unstructured":"Wright G, Manser RL, Byrnes G et al (2006) Surgery for non-small cell lung cancer: systematic review and meta-analysis of randomised controlled trials. Thorax 61:597\u2013603","journal-title":"Thorax"},{"key":"251_CR8","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1378\/chest.117.2.374","volume":"117","author":"M.T. Rens Van","year":"2000","unstructured":"Van Rens MT, de la Rivi\u00e8re AB, Elbers HR, van Den Bosch JM (2000) Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA. Chest 117:374\u2013379","journal-title":"Chest"},{"key":"251_CR9","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1002\/(SICI)1097-0142(19991101)86:9<1867::AID-CNCR31>3.0.CO;2-9","volume":"86","author":"W.A. Fry","year":"1999","unstructured":"Fry WA, Phillips JL, Menck HR (1999) Ten-year survey of lung cancer treatment and survival in hospitals in the United States: a national cancer data base report. Cancer 86:1867\u20131876","journal-title":"Cancer"},{"key":"251_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0140-6736(92)90997-H","volume":"339","author":"Early Breast Cancer Trialists\u2019 Collaborative Group","year":"1992","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (1992) Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy: 133 randomised trials involving 31000 recurrences and 24000 deaths among 75000 women. Lancet 339:1\u201315, 71\u201385","journal-title":"Lancet"},{"key":"251_CR11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/jnci\/95.2.105","volume":"95","author":"J.B. Trimbos","year":"2003","unstructured":"Trimbos JB, Parmar M, Vergote I et al (2003) International Collaborative Ovarian Neoplasm trial 1 and adjuvant chemotherapy in Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma. J Natl Cancer Inst 95: 105\u2013112","journal-title":"J Natl Cancer Inst"},{"key":"251_CR12","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1056\/NEJMoa032709","volume":"350","author":"T. Andr\u00e9","year":"2004","unstructured":"Andr\u00e9 T, Boni C, Mounedji-Boudiaf L et al (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350:2343\u20132351","journal-title":"N Engl J Med"},{"key":"251_CR13","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/bmj.311.7010.899","volume":"311","author":"Non-small Cell Lung Cancer Collaborative Group","year":"1995","unstructured":"Non-small Cell Lung Cancer Collaborative Group (1995) Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 311:899\u2013909","journal-title":"BMJ"},{"key":"251_CR14","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1056\/NEJM200010263431703","volume":"343","author":"S.M. Keller","year":"2000","unstructured":"Keller SM, Adak S, Wagner H et al (2000) A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small cell lung cancer. Eastern Cooperative Oncology Group. N Engl J Med 343:1217\u20131222","journal-title":"N Engl J Med"},{"key":"251_CR15","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/jnci\/djg059","volume":"95","author":"G.V. Scagliotti","year":"2003","unstructured":"Scagliotti GV, Fossati R, Torri V et al (2003) Randomized study of adjuvant chemotherapy for completely resected stage I, II or IIIA non-small cell lung cancer. J Natl Cancer Inst 95:1453\u20131461","journal-title":"J Natl Cancer Inst"},{"key":"251_CR16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejcts.2004.03.041","volume":"26","author":"D. Waller","year":"2004","unstructured":"Waller D, Peake MD, Stephens RJ et al (2004) Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial. Eur J Cardiothorac Surg 26:173\u2013182","journal-title":"Eur J Cardiothorac Surg"},{"key":"251_CR17","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa031644","volume":"350","author":"The International Adjuvant Lung Cancer Trial Collaborative Group","year":"2004","unstructured":"The International Adjuvant Lung Cancer Trial Collaborative Group (2004) Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small cell lung cancer. N Engl J Med 350:351\u2013360","journal-title":"N Engl J Med"},{"key":"251_CR18","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1056\/NEJMoa043623","volume":"352","author":"T. Winton","year":"2005","unstructured":"Winton T, Livingston R, Johnson D et al (2005) Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 352:2589\u20132597","journal-title":"N Engl J Med"},{"key":"251_CR19","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S1470-2045(06)70804-X","volume":"7","author":"J.Y. Douillard","year":"2006","unstructured":"Douillard JY, Rosell R, de Lena M et al (2006) Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncol 7:719\u2013727","journal-title":"Lancet Oncol"},{"key":"251_CR20","doi-asserted-by":"crossref","first-page":"366S","DOI":"10.1200\/jco.2006.24.18_suppl.7008","volume":"24","author":"J.P. Pignon","year":"2006","unstructured":"Pignon JP, Tribodet H, Scagliotti GV et al (2006) Lung Adjuvant Cisplatin Evaluation(LACE): a pooled analysis of 5 randomized trials including 4584 patients. J Clin Oncol 24:366S [Abstract No 7008 2006 ASCO Annual Meeting]","journal-title":"J Clin Oncol"},{"key":"251_CR21","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1200\/JCO.1996.14.4.1048","volume":"14","author":"H. Wada","year":"1996","unstructured":"Wada H, Hitomi S, Teramatsu T (1996) Adjuvant chemotherapy after complete resection in non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery. J Clin Oncol 14:1048\u20131054","journal-title":"J Clin Oncol"},{"key":"251_CR22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0169-5002(03)00032-1","volume":"40","author":"C. Endo","year":"2003","unstructured":"Endo C, Saito Y, Iwanami H et al (2003) A randomized trial of postoperative UFT therapy in pathological stage I, II non-small cell lung cancer: North-east Japan Study Group for Lung Cancer Surgery. Lung Cancer 40:181\u2013186","journal-title":"Lung Cancer"},{"key":"251_CR23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/annonc\/mdi008","volume":"16","author":"M. Nakawava","year":"2005","unstructured":"Nakawava M, Tanaka F, Tsubota N et al; West Japan Study Group for Lung Cancer Surgery (2005) A randomized phase III trial f adjuvant chemotherapy with UFT for completely resected pathological stage I non-small-cell lung cancer: the West Japan Study Group for Lung Cancer Surgery( WJSG)-the 4th study. Ann Oncol 16:75\u201380","journal-title":"Ann Oncol"},{"key":"251_CR24","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/sj.bjc.6603336","volume":"95","author":"K. Nakagawa","year":"2006","unstructured":"Nakagawa K, Tada H, Akashi A et al (2006) Randomised study of adjuvant chemotherapy for completely resected p-stage I-IIIA non-small cell lung cancer. Br J Cancer 95:817\u2013821","journal-title":"Br J Cancer"},{"key":"251_CR25","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa032792","volume":"350","author":"H. Kato","year":"2004","unstructured":"Kato H, Ichinose Y, Ohta M et al (2004) A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N Engl J Med 350:1713\u20131721","journal-title":"N Engl J Med"},{"key":"251_CR26","doi-asserted-by":"crossref","unstructured":"Stewart LA, Burdett S, Tierney JF et al (2007) Surgery and adjuvant chemotherapy (CT) compared to surgery alone in non-small cell lung cancer (NSCLC): a meta-analysis using individual patient data (IPD) from randomized clinical trials (RCT). J Clin Oncol 25 [Abstract No 7552 2007 ASCO Annual Meeting]","DOI":"10.1200\/jco.2007.25.18_suppl.7552"},{"key":"251_CR27","doi-asserted-by":"crossref","first-page":"7019","DOI":"10.1200\/jco.2004.22.14_suppl.7019","volume":"22","author":"G.M. Strauss","year":"2004","unstructured":"Strauss GM, Herndon JE, Maddaus MA et al (2004) Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in stage IB non-small cell lung cancer (NSCLC): report of Cancer and Leukemia Group B (CALGB) protocol 9633. J Clin Oncol 22:7019","journal-title":"J Clin Oncol"},{"key":"251_CR28","doi-asserted-by":"crossref","unstructured":"Strauss GM, Herndon JE, Maddaus MA et al (2006) Adjuvant chemotherapy in stage IB non-small cell lung cancer (NSCLC): update of cancer and leukemia Group B protocol 9633. J Clin Oncol 24 [Abstract-No 7007 2006 ASCO Annual Meeting]","DOI":"10.1200\/jco.2006.24.18_suppl.7007"},{"key":"251_CR29","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/JTO.0b013e318074bbd0","volume":"2","author":"C.G. Azzoli","year":"2007","unstructured":"Azzoli CG, Krug LM, Miller VA et al (2007) A phase II tolerability study of cisplatin plus docetaxel as adjuvant chemotherapy for resected non-small cell lung cancer. J Thorac Oncol 2: 638\u2013644","journal-title":"J Thorac Oncol"},{"key":"251_CR30","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/01.JTO.0000263710.54073.b3","volume":"2","author":"S.J. Feigenberg","year":"2007","unstructured":"Feigenberg SJ, Hanlon AL, Langer C et al (2007) A phase II study of concurrent carboplatin and paclitaxel and thoracic radiotherapy for completely resected stage II and IIIA non-small cell lung cancer. J Thorac Oncol 2:287\u2013292","journal-title":"J Thorac Oncol"},{"key":"251_CR31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2407-7-77","volume":"7","author":"M. Kreuter","year":"2007","unstructured":"Kreuter M, Vansteenkiste J, Griesinger F et al (2007) Trial on refinement of early stage non-small cell lung cancer. Adjuvant chemotherapy with pemetrexed and cisplatin versus vinorelbine and cisplatin: the TREAT protocol. BMC Cancer 7:77","journal-title":"BMC Cancer"},{"key":"251_CR32","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1200\/JCO.2005.12.120","volume":"23","author":"J.D. Bradley","year":"2005","unstructured":"Bradley JD, Paulus R, Graham MV et al (2005) Phase II of postoperative adjuvant paclitaxel\/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group-RTOG 9705. J Clin Oncol 23:3480\u20133487","journal-title":"J Clin Oncol"},{"key":"251_CR33","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1002\/1097-0142(20011015)92:8<2142::AID-CNCR1556>3.0.CO;2-R","volume":"92","author":"F.A. Greco","year":"2001","unstructured":"Greco FA, Burris HA 3rd, Gray JR et al (2001) Paclitaxel and carboplatin adjuvant chemotherapy alone or with radiotherapy for resected nonsmall cell lung carcinoma: a feasibility study of the Minnie Pearl Cancer Research Network. Cancer 92:2142\u20132147","journal-title":"Cancer"},{"key":"251_CR34","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00280-006-0391-6","volume":"60","author":"M. Kawamura","year":"2007","unstructured":"Kawamura M, Eguchi K, Izumi Y et al (2007) Phase II trial of gemcitabine and docetaxel in patients with completely resected stage IIA-IIIA non-small-cell lung cancer. Cancer Chemother Pharmacol 60:495\u2013501","journal-title":"Cancer Chemother Pharmacol"},{"key":"251_CR35","doi-asserted-by":"crossref","first-page":"4999","DOI":"10.1200\/JCO.2005.09.017","volume":"23","author":"C. Hamada","year":"2005","unstructured":"Hamada C, Tanaka F, Ohta M et al (2005) Meta-analysis of postoperative adjuvant chemotherapy with tegafur-uracil in non-small-cell lung cancer. J Clin Oncol 23:4999\u20135006","journal-title":"J Clin Oncol"},{"key":"251_CR36","doi-asserted-by":"crossref","first-page":"5506","DOI":"10.1200\/JCO.2007.14.1226","volume":"25","author":"K.M. Pisters","year":"2007","unstructured":"Pisters KM, Evans WK, Azzoli CG et al (2007) Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I\u2013IIIA resectable non small-cell lung cancer guideline. J Clin Oncol 25:5506","journal-title":"J Clin Oncol"},{"key":"251_CR37","unstructured":"National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology. Available at www.nccn.org\/professionals\/physician_gls\/default.asp"},{"key":"251_CR38","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0360-3016(00)00509-5","volume":"47","author":"Q.F. Feng","year":"2000","unstructured":"Feng QF, Wang M, Wang LJ et al (2000) A study of postoperative radiotherapy in patients with non-small-cell lung cancer: a randomized trial. Int J Radiat Oncol Biol Phys 47:925\u2013929","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"251_CR39","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/(SICI)1097-0142(19990715)86:2<265::AID-CNCR10>3.0.CO;2-B","volume":"86","author":"B. Dautzenberg","year":"1999","unstructured":"Dautzenberg B, Arriagada R, Chammard AB et al (1999) A controlled study of postoperative radiotherapy for patients with completely resected non-small cell lung carcinoma. Groupe d\u2019Etude et de Traitement des Cancers Bronchiques. Cancer 86:265\u2013273","journal-title":"Cancer"},{"key":"251_CR40","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/bjc.1996.413","volume":"74","author":"R.J. Stephens","year":"1996","unstructured":"Stephens RJ, Irling DJ, Bleehen NM et al (1996) The role of post-operative radiotherapy in non-small-cell lung cancer: a multicentre randomised trial in patients with pathologically staged T1-2, N1-2, M0 disease. Medical Research Council Lung Cancer Working Party. Br J Cancer 74:632\u2013639","journal-title":"Br J Cancer"},{"key":"251_CR41","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0140-6736(98)06341-7","volume":"352","author":"PORT Meta-analysis Trialists Group","year":"1998","unstructured":"PORT Meta-analysis Trialists Group (1998) Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patients data from nine randomised controlled trials. Lancet 352:257\u2013263","journal-title":"Lancet"},{"key":"251_CR42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0167-8140(01)00478-9","volume":"62","author":"L. Trodella","year":"2002","unstructured":"Trodella L, Granone P, Valente S et al (2002) Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial. Radiother Oncol 62:11\u201319","journal-title":"Radiother Oncol"},{"key":"251_CR43","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1200\/JCO.2005.04.177","volume":"23","author":"T. Hoang","year":"2005","unstructured":"Hoang T, Xu R, Schiller JH et al (2005) Clinical model to predict survival in chemona\u00efve patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimens based on eastern cooperative oncology group data. J Clin Oncol 23:175\u2013183","journal-title":"J Clin Oncol"},{"key":"251_CR44","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0022-5223(19)36246-4","volume":"94","author":"The Lung Cancer Study Group","year":"1987","unstructured":"The Lung Cancer Study Group (1987) Postoperative T1N0 non-small cell lung cancer. Squamous versus nonsquamous recurrences. J Thorac Cardiovasc Surg 94:349\u2013354","journal-title":"J Thorac Cardiovasc Surg"},{"key":"251_CR45","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0003-4975(10)62281-3","volume":"38","author":"P.C. Pairolero","year":"1984","unstructured":"Pairolero PC, Williams DE, Bergstralh EJ et al (1984) Postsurgical stage I bronchogenic carcinoma: morbid implications of recurrence disease. Ann Thorac Surg 38:331\u2013338","journal-title":"Ann Thorac Surg"},{"key":"251_CR46","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1378\/chest.108.1.246","volume":"108","author":"C.F. Mountain","year":"1995","unstructured":"Mountain CF (1995) New prognostic factors in lung cancer. Biologic prophets of cancer cell aggression. Chest 108:246\u2013254","journal-title":"Chest"},{"key":"251_CR47","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMoa060467","volume":"355","author":"A. Potti","year":"2006","unstructured":"Potti A, Mukherjee S, Petersen R et al (2006) A genomic strategy to refine prognosis in earlystage non-small-cell lung cancer. N Engl J Med 355:570\u2013580","journal-title":"N Engl J Med"},{"key":"251_CR48","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa060096","volume":"356","author":"H.-Y. Chen","year":"2007","unstructured":"Chen H-Y, Yu S-L, Chen CH et al (2007) A five-gene signature and clinical outcome in non-small-cell lung cancer. N Engl J Med 356:11\u201320","journal-title":"N Engl J Med"},{"key":"251_CR49","first-page":"959","volume":"14","author":"R. Altaha","year":"2004","unstructured":"Altaha R, Liang X, Yu JJ, Reed E (2004) Excision repair cross complementing-group 1: gene expression and platinum resistance. Int J Mol Med 14: 959\u2013970","journal-title":"Int J Mol Med"},{"key":"251_CR50","first-page":"2286","volume":"8","author":"R.V. Lord","year":"2002","unstructured":"Lord RV, Brabender J, Gandara D et al (2002) Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer. Clin Cancer Res 8:2286\u20132291","journal-title":"Clin Cancer Res"},{"key":"251_CR51","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJMoa060570","volume":"355","author":"K.A. Olaussen","year":"2006","unstructured":"Olaussen KA, Dunant A, Fouret P et al (2006) DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. N Engl J Med 355:983\u2013991","journal-title":"N Engl J Med"},{"key":"251_CR52","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1200\/JCO.2004.12.002","volume":"22","author":"G. Bepler","year":"2004","unstructured":"Bepler G, Sharma S, Cantor A et al (2004) RMM1 and PTEN as prognostic parameters for overall and disease-free survival in patients with non-small-cell lung cancer. J Clin Oncol 22: 1878\u20131885","journal-title":"J Clin Oncol"},{"key":"251_CR53","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJMoa065411","volume":"356","author":"Z. Zheng","year":"2007","unstructured":"Zheng Z, Chen T, Li X et al (2007) DNA synthesis and repair genes RMM1 and ERCC1 in lung cancer. N Engl J Med 356:800\u2013808","journal-title":"N Engl J Med"},{"key":"251_CR54","doi-asserted-by":"crossref","unstructured":"Rosell R, Jassem M, Skrzypski M et al (2007) Increased BRCA1 mRNA: an independent prognostic variable in completely resected chemo-na\u00efve non-small cell lung cancer (NSCLC) patients (p). [Abstract No. 7551 2007 ASCO Annual Meeting]","DOI":"10.1097\/01.JTO.0000283279.35822.f1"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-008-0251-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-008-0251-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-008-0251-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T17:13:25Z","timestamp":1588958005000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-008-0251-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":54,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["251"],"URL":"https:\/\/doi.org\/10.1007\/s12094-008-0251-x","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}